Arkolith/Insider Trading/ARTV/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerArtiva Biotherapeutics, Inc. (ARTV) · full profile →Form 4 · filed May 13, 2026
Net Buying
Open-Market Buys
$75.0M
Open-Market Sells
$0
Net Open-Market Flow
$75.0M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Buy(P)6.5M$11.52$75.0M15.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Buy(P)2.2M$11.52$25.0M2.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000491) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML